Cargando…
COVID-19 vaccination in patients receiving dialysis
Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these patients and a personalized approach is therefore necessary. Importantly, given the enhanced infection risks associated with...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503726/ https://www.ncbi.nlm.nih.gov/pubmed/34635831 http://dx.doi.org/10.1038/s41581-021-00499-z |
_version_ | 1784581190912573440 |
---|---|
author | Wilde, Benjamin Korth, Johannes Jahn, Michael Kribben, Andreas |
author_facet | Wilde, Benjamin Korth, Johannes Jahn, Michael Kribben, Andreas |
author_sort | Wilde, Benjamin |
collection | PubMed |
description | Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these patients and a personalized approach is therefore necessary. Importantly, given the enhanced infection risks associated with dialysis, current vaccines do not replace non-pharmacological measures to prevent infection. |
format | Online Article Text |
id | pubmed-8503726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85037262021-10-12 COVID-19 vaccination in patients receiving dialysis Wilde, Benjamin Korth, Johannes Jahn, Michael Kribben, Andreas Nat Rev Nephrol Comment Patients receiving dialysis are at high risk of contracting SARS-CoV-2 and developing severe COVID-19. Established SARS-CoV-2 vaccination schemes might lack efficacy in these patients and a personalized approach is therefore necessary. Importantly, given the enhanced infection risks associated with dialysis, current vaccines do not replace non-pharmacological measures to prevent infection. Nature Publishing Group UK 2021-10-11 2021 /pmc/articles/PMC8503726/ /pubmed/34635831 http://dx.doi.org/10.1038/s41581-021-00499-z Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Wilde, Benjamin Korth, Johannes Jahn, Michael Kribben, Andreas COVID-19 vaccination in patients receiving dialysis |
title | COVID-19 vaccination in patients receiving dialysis |
title_full | COVID-19 vaccination in patients receiving dialysis |
title_fullStr | COVID-19 vaccination in patients receiving dialysis |
title_full_unstemmed | COVID-19 vaccination in patients receiving dialysis |
title_short | COVID-19 vaccination in patients receiving dialysis |
title_sort | covid-19 vaccination in patients receiving dialysis |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503726/ https://www.ncbi.nlm.nih.gov/pubmed/34635831 http://dx.doi.org/10.1038/s41581-021-00499-z |
work_keys_str_mv | AT wildebenjamin covid19vaccinationinpatientsreceivingdialysis AT korthjohannes covid19vaccinationinpatientsreceivingdialysis AT jahnmichael covid19vaccinationinpatientsreceivingdialysis AT kribbenandreas covid19vaccinationinpatientsreceivingdialysis |